BioSpace News Archive

BioCapital

When Chemo and Surgery Fails, Targeted Radiation Is an Option for Kids With Liver Cancer

Luckily, primary malignant liver tumors in children are rare. They account for only 1 to 2 percent of all childhood cancers. The most common treatment is surgery and chemotherapy. However, not all can be treated by surgery and sometimes they do not respond to chemotherapy.

November 8, 2018
·
3 min read
·
Mark Terry
Career Advice

5 Easy Ways to Overcome Job Interview Jitters

Going into a job interview, especially when you really want the job or don’t have much experience on the job market, can be a nerve-wracking few hours for many candidates.

November 8, 2018
·
2 min read
·
Editorial Staff
Business

Cochlear and GN Hearing Strengthen Technology and Commercial Alliance to Develop Best-in-Class Integrated Hearing Solutions

Cochlear Limited and GN today signed a new agreement to significantly expand their Smart Hearing Alliance collaboration.

November 8, 2018
·
6 min read
Business

BioArctic Interim Report January - September 2018

BioArctic reports strong BAN2401 Phase 2b results for Alzheimer patients.

November 8, 2018
·
8 min read
Business

IRRAS AB (PUBL) Interim Report January-September 2018

Preparation for US launch of IRRAflow® ongoing, CE mark catheter re-certification now expected at YE 2018

November 8, 2018
·
4 min read
Business

Perrigo Company plc Reports Third Quarter 2018 Financial Results

Realized third quarter 2018 GAAP (“reported”) net sales of $1.1 billion, reported net loss of $68 million compared to a net income of $45 million last year and reported diluted loss per share of $0.49 compared to net earnings per share (“EPS”) of $0.31 last year

November 8, 2018
·
27 min read
Business

Triple-S Management Corporation Reports Third Quarter 2018 Results

Triple-S Management Corporation today announced its third quarter 2018 results.

November 8, 2018
·
25 min read
Business

MYOS RENS Technology Signs Distribution Agreement With Miller Veterinary Supply East To Bring Innovative MYOS Canine Muscle Formula™ To 6,000+ Veterinary Hospitals

First Distribution Agreement for MYOS Canine Muscle Formula™

November 8, 2018
·
4 min read
Job Trends

Marker Therapeutics to Present at Three Upcoming November 2018 Healthcare Conferences

Marker Therapeutics, Inc. today announced that its President and CEO, Peter L. Hoang, will participate in three upcoming healthcare conferences.

November 8, 2018
·
4 min read
Drug Development

NextCure to Present Preclinical Data on NC318, a Novel Immunomedicine Targeting Siglec-15, at the Society for Immunotherapy of Cancer’s (SITC) 33rd Annual Meeting

NextCure, Inc. today announced that preclinical data supporting the development of its lead drug candidate, NC318, will be presented in a poster session at the Society for Immunotherapy of Cancer 33rd Annual Meeting being held November 7th – 11th 2018 in Washington, D.C.

November 8, 2018
·
2 min read